Cytecom – rapid antimicrobial susceptibility test

– rapid, phenotypic ASTs
– Compact, R&D-ready device: optimise bench space and work safely with hazard group organisms in safety cabinets
– Single-cell level data allows for population analysis profiling (heteroresistance)
– Cutting-edge innovation: optical electrophysiology rapidly assesses bacterial and fungal viability by measuring membrane
potential responses to electrical stimulation – a process universal to all life forms.

We are actively seeking partners for clinical evaluations, fundamental research in bacterial electrophysiology, and companion diagnostics for drug development.

Cytecom is tackling a pressing issue in healthcare: the slow and ineffective diagnosis of antibiotic-resistant infections. With a market size exceeding $3.5 billion globally, our rapid diagnostic test addresses the urgent need for faster detection, thereby saving lives. Cytecom’s solution, powered by cutting-edge optical electrophysiology, detects resistant bacteria in just 45 seconds, enabling doctors to prescribe targeted antibiotics 48 times faster. Our dedicated team of experts in microbiology, optics, and engineering is committed to revolutionising diagnostic microbiology and improving patient outcomes worldwide.

CytePulse – electrophysiology research tool that seamlessly integrates with live cell imaging microscopes. Researchers can precisely deliver electrical pulses based on pre-programmed patterns, enabling advanced investigations into bioelectricity. The inclusion of a plug-in module for fluorescent microscopy expands its versatility.